Elite Pharmaceuticals Inc
OTC:ELTP
Elite Pharmaceuticals Inc
OTC:ELTP
Price:
0.3881
USD
-0.49%
Market Cap:
$418m
Relative Value
The Relative Value of one
ELTP
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 0.3881 USD,
Elite Pharmaceuticals Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ELTP Relative Value
HIDDEN
Multiples Across Competitors
ELTP Competitors Multiples
Elite Pharmaceuticals Inc Competitors
Elite Pharmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Elite Pharmaceuticals Inc
OTC:ELTP
|
417m USD | 3 | 9.6 | 7.8 | 8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
908.7B USD | 13.6 | 42.8 | 28.9 | 30.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581.3B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
256.6B CHF | 4.2 | 19.9 | 11.8 | 13.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
224.3B GBP | 5.1 | 29.2 | 16.2 | 22.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
233.8B CHF | 5.4 | 21.6 | 13.3 | 17.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288.4B USD | 4.4 | 15.7 | 9.7 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 11 | 8.1 | 9.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.5B USD | 2.5 | 19.9 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122B USD | 2.5 | 17.3 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
